April 2017 Issue Table Of Contents

From The Editor

• Are We Encouraging The New Pharma Entrepreneurs?

Feature Articles

• What’s The Backbone Of Vivek Ramaswamy’s Success?
• Journey To The Corporate Boardroom
• Leading Business With Science: Geert Cauwenbergh of RXi
• A Companion Diagnostics Primer From Roche Diagnostics’ CMO

Capitol Perspectives

• Repeal & Replace Confronts Trump’s Base

Companies To Watch

• Aridis Pharmaceuticals

CEO Corner

• Understanding The Many Faces Of Innovation

Inside The Industry

• Tackling The Challenges Of A Rare-Disease Clinical Trial
• Janssen Turns Clinical Data Over To Patients
• State Funding Fuels Michigan’s Life Sciences Industry
• The Worldwide War On Counterfeit Medicines
• Diversity In The Biopharma Boardroom: Moving Past Good Intentions

Leadership Lessons

• How To Diagnose And Treat Team Conflict

Ask The Board

• What Are Some Common Mistakes To Avoid When Fundraising For A Biopharma Or Med Device Startup?
• What’s The Fastest Route To Creating A High-Performing Team?
• What Role Is Played By State Bioscience Associations In The Current Healthcare Debate?